NAM
RMD icon

Nutshell Asset Management’s ResMed RMD Stock Holding History

Nutshell Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-36,430
Closed -$8.18M – 49
2026
Q1 		$8.18M Buy
+36,430
New +$9.08M 4.44% 10
2025
Q2 		– Sell
-14,050
Closed -$3.15M – 33
2025
Q1 		$3.15M Buy
14,050
+4,304
+44% +$1M 1.64% 21
2024
Q4 		$2.23M Buy
+9,746
New +$2.35M 1.41% 23

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nutshell Asset Management's RMD Position: Q2 2026 in Review

Nutshell Asset Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 36,430 shares — an estimated $8.18M sold.

Nutshell Asset Management first reported a position in RMD in Q4 2024 and held it in 3 quarters. The position peaked at $8.18M in Q1 2026. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Nutshell Asset Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Nutshell Asset Management sold 36,430 ResMed shares in Q2 2026, an estimated $8.18M.
  • Nutshell Asset Management first reported a position in ResMed in Q4 2024 and held it in 3 quarters.
  • Nutshell Asset Management's ResMed position peaked at $8.18M in Q1 2026.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Nutshell Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.